Most Successful Tactics Pharmacists Can Use to Improve Adherence

David Nau, PhD, RPh, FAPhA, president of Pharmacy Quality Solutions, talks about the most successful tactics pharmacists can use to improve adherence.

David Nau, PhD, RPh, FAPhA, president of Pharmacy Quality Solutions, talks about the most successful tactics pharmacists can use to improve adherence.

This video was recorded at APhA's 2015 annual meeting in San Diego, California.

Related Videos
Credit: wladimir1804 - stock.adobe.com
Women buying contraceptive pills in the pharmacy | Image credit: Antonioguillem - stock.adobe.com
Healthcare technology | Image credit: ipopba | stock.adobe.com
Medical science laboratory | Image credit: alphaspirit - stock.adobe.com
Gastroenterologist using digital x-ray of human intestine holographic scan projection 3D rendering | Image Credit: sdecoret - stock.adobe.com
Supreme Court | Image credit: steheap - stock.adobe.com
Pharmacists talking with a nurse | Image credit: Jacob Lund - stock.adobe.com
Related Content

Counsel Patients On the Range of Treatments for Depression

May 26th 2023

BONUS: American Association of Pharmacy Technicians Convention 2023

May 24th 2023

Migraine: Much Progress Made, Significantly More Needed

May 26th 2023

Independent Rx Forum - Congressional Trends on PBM Reform

May 23rd 2023

FDA Approves Pfizer’s Paxlovid for Treatment of COVID-19 in Adults

May 25th 2023

FDA Approves Celltroin’s Yuflyma as Humira Biosimilar for 8 Disease States

May 25th 2023

Counsel Patients On the Range of Treatments for Depression

May 26th 2023

BONUS: American Association of Pharmacy Technicians Convention 2023

May 24th 2023

Migraine: Much Progress Made, Significantly More Needed

May 26th 2023

Independent Rx Forum - Congressional Trends on PBM Reform

May 23rd 2023

FDA Approves Pfizer’s Paxlovid for Treatment of COVID-19 in Adults

May 25th 2023

FDA Approves Celltroin’s Yuflyma as Humira Biosimilar for 8 Disease States

May 25th 2023

Counsel Patients On the Range of Treatments for Depression

May 26th 2023

BONUS: American Association of Pharmacy Technicians Convention 2023

May 24th 2023

Migraine: Much Progress Made, Significantly More Needed

May 26th 2023

Independent Rx Forum - Congressional Trends on PBM Reform

May 23rd 2023

FDA Approves Pfizer’s Paxlovid for Treatment of COVID-19 in Adults

May 25th 2023

FDA Approves Celltroin’s Yuflyma as Humira Biosimilar for 8 Disease States

May 25th 2023
© 2023 MJH Life Sciences

All rights reserved.